AlphaQuest’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-369
Closed -$397K 1132
2025
Q4
$397K Buy
369
+237
+180% +$227K 0.02% 996
2025
Q3
$101K Sell
132
-193
-59% -$144K 0.01% 1727
2025
Q2
$253K Buy
325
+50
+18% +$38.9K 0.02% 987
2025
Q1
$227K Sell
275
-179
-39% -$149K 0.02% 926
2024
Q4
$350K Sell
454
-599
-57% -$496K 0.05% 636
2024
Q3
$933K Buy
1,053
+238
+29% +$214K 0.08% 388
2024
Q2
$738K Sell
815
-155
-16% -$124K 0.1% 326
2024
Q1
$755K Buy
970
+433
+81% +$308K 0.13% 257
2023
Q4
$313K Buy
+537
New +$313K 0.07% 500

Other funds holding LLY

AlphaQuest's LLY Position: Q1 2026 in Review

AlphaQuest sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 369 shares — an estimated $397K sold.

AlphaQuest first reported a position in LLY in Q4 2023 and held it in 9 quarters. The position peaked at $933K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AlphaQuest reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 369 Eli Lilly shares in Q1 2026, an estimated $397K.
  • AlphaQuest first reported a position in Eli Lilly in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Eli Lilly position peaked at $933K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.